(165 days)
The Datex-Ohmeda TuffSat 3000 Pulse Oximeter is a non-invasive, spot-check, oxygen saturation and pulse rate monitor. It operates only on battery power using existing Datex-Ohmeda disposable and reusable finger and ear sensors labeled for patients ranging from neonates to adults.
The Datex-Ohmeda TuffSat 3000 Pulse Oximeter is a noninvasive, spot-check, oxygen saturation and pulse rate monitor. It operates only on battery power using existing Datex-Ohmeda disposable and reusable finger and ear sensors labeled for patients ranging from neonates to adults.
The Datex-Ohmeda TuffSat 3000 Pulse Oximeter is a non-invasive, spot-check, oxygen saturation and pulse rate monitor. The device was validated through rigorous testing, both in-house and at a Nationally Recognized Testing Lab, in accordance with applicable portions of several standards including IEC 601-1, IEC 601-1-1, IEC 601-1-2, CAN/CSA C22.2 #601, UL 2601-1, ISO 9919, EN 865, ASTM 1415, EN 1441 and IEC 601-1-4. The software for the device was developed following a robust software development process and was specified and validated by Datex-Ohmeda.
Based on the provided document, the following information regarding the acceptance criteria and study cannot be fully extracted:
- A table of acceptance criteria and the reported device performance.
- Sample size used for the test set and the data provenance.
- Number of experts used to establish the ground truth for the test set and their qualifications.
- Adjudication method for the test set.
- If a multi-reader multi-case (MRMC) comparative effectiveness study was done.
- Effect size of how much human readers improve with AI vs without AI assistance.
- If a standalone (i.e., algorithm only without human-in-the-loop performance) was done.
- The type of ground truth used.
- The sample size for the training set.
- How the ground truth for the training set was established.
The document indicates that the device was deemed "substantially equivalent" to predicate devices (Ohmeda 3770 / 3775 Handheld Pulse Oximeters) based on design concepts, technologies, and materials, and compliance with mentioned standards. However, specific performance metrics against defined acceptance criteria (e.g., accuracy, precision, bias) are not detailed in this summary. The summary highlights adherence to safety and performance standards rather than providing a direct comparison of a specific performance metric against a quantitative acceptance criterion.
{0}------------------------------------------------
MAR 3 1 2000
Summary of Safety and Effectiveness
October 15, 1999
| Subject: | 510(k) Summary of Safety and Effectiveness Information for the Datex-OhmedaTuffsat 3000 Pulse Oximeter. |
|---|---|
| Proprietary: | Datex-Ohmeda TuffSat 3000 Pulse Oximeter |
| Common: | Oximeter |
| Classification: | Oximeter Class II – 21 CFR870.2700 – 74 DQA |
The 510(k) summary of safety and effectiveness information is submitted in accordance with the requirements of SMDA of 1990 and 1992.
The Datex-Ohmeda TuffSat 3000 Pulse Oximeter is substantially equivalent to the following currently marketed devices:
- . Ohmeda 3770 / 3775 Handheld Pulse Oximeters
The Datex-Ohmeda TuffSat 3000 Pulse Oximeter is a noninvasive, spot-check, oxygen saturation and pulse rate monitor. It operates only on battery power using existing Datex-Ohmeda disposable and reusable finger and ear sensors labeled for patients ranging from neonates to adults.
There is no change in the fundamental scientific technology nor the intended use of the device from that of the predicate device.
The Datex-Ohmeda TuffSat 3000 Pulse Oximeter was designed to comply with applicable portions of the following standards:
| 1.* IEC 601-1 | Medical Electrical Equipment - General Requirements for Safety |
|---|---|
| 2. IEC 601-1-1 | Safety Requirements for Medical Electrical Systems |
| 3.* IEC 601-1-2 | Electromagnetic compatibility - Requirements and tests |
| 4. CAN/CSA C22.2 #601 | Medical Electrical Equipment - General Requirements for Safety |
| 5. UL 2601-1 | Medical Electrical Equipment - General Requirements for Safety |
| 6. ISO 9919 | Pulse Oximeters for Medical Use - Requirements |
| 7. EN 865 | Pulse Oximeters - Particular Requirements |
| 8.* ASTM 1415 | Standard Specification for Pulse Oximeters |
| 9. EN 1441 | Medical Devices - Risk Analysis |
| 10. IEC 601-1-4 | Programmable Electrical Medical Systems |
- Report / certificate included in this submission
The Datex-Ohmeda 3770 / 3775 Handheld and TuffSat 3000 Pulse Oximeters are substantially equivalent in design concepts, technologies and materials. The Datex-Ohmeda TuffSat 3000 Pulse Oximeter was validated through rigorous testing performed both in-house and at a Nationally Recognized Testing Lab. This testing supports the compliance of the Datex-Ohmeda TuffSat 3000 Pulse Oximeter to the above mentioned standards.
Additionally, the software for the Datex-Ohmeda TuffSat 3000 Pulse Oximeter was developed following a robust software development process and was specified and validated by Datex-Ohmeda.
{1}------------------------------------------------
Image /page/1/Picture/1 description: The image is a black and white logo. The logo is circular and contains an image of an eagle. The words "Department of Health & Human Services - USA" are written around the eagle in a circular fashion.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR 3 1 2000
Mr. Dale Thanig Datex-Ohmeda, Inc. 1315 West Century Drive Louisville, CO 80027-9560
K993512 Re : Datex-Ohmeda TuffSat 3000 Pulse Oximeter Regulatory Class: II (two) Product Code: 74 DQA February 29, 2000 Dated: Received: March 1, 2000
Dear Mr. Thanig:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to leqally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such Existing major regulations affecting your device additional controls. can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
{2}------------------------------------------------
Page 2 - Mr. Dale Thaniq
This letter will allow you to beqin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the requlation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.qov/cdrh/dsma/dsmamain.html".
Sincerely yours,
teame Awertedn fe;
James E. Dillard III Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
Indications for Use
510(k) Number (if known): _K993512
Datex-Ohmeda TuffSat 3000 Pulse Oximeter Device Name:
Indications for Use:
The Datex-Ohmeda TuffSat 3000 Pulse Oximeter is a non-invasive, spot-check, oxygen saturation and pulse rate monitor. It operates only on battery power using existing Datex-Ohmeda disposable and reusable finger and ear sensors labeled for patients ranging from neonates to adults.
US federal and Canadian laws restrict the sale of this device by or on the order of a licensed medical practitioner.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurence of CDRH, Office of Device Evaulation (ODE)
Luan A Weiteihn
(Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devices
510K Number: K 993572
OR
Prescription Use (Per 21CFR801.109)
Over-The-Counter
§ 870.2700 Oximeter.
(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).